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Actions of angiotensin II on the isolated spontaneously
hypertensive rat kidney
THOMAS H. STEELE, JEANNE H. GOTTSTEIN, LAURA CHALLONER-HUE,
and JOHNNIE L. UNDERWOOD
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Actions of angiotensin II on the isolated spontaneously hypertensive rat
kidney. We studied the effects of angiotensin II (All) on isolated
spontaneously hypertensive rat (SHR) and Wistar-Kyoto control
(WKY) kidneys utilizing a recirculating cell-free perfusate. Sufficient
All was infused to increase renal vascular resistance (RVR) by approxi-
mately 50%. When the perfusion pressure was allowed to increase with
RVR during All infusion, significant increases in the glomerular filtra-
tion rate (GFR), urine flow, and electrolyte excretion occurred in both
the SHR and the WKY kidneys. However, when the increase in
perfusion pressure was prevented, All increased the GFR of SHR
kidneys but had no effect on the GFR of WKY. In contrast to WKY,
All increased the GFR, urine flow, and sodium excretion of SHR
kidneys as much at "normotensive" perfusion pressures as at "hyper-
tensive" pressures. However, the 'normotensive" perfusion pressures
utilized in these studies were less than the blood pressure of the SHR in
vivo. Accordingly, the response of SHR kidneys to All was assessed
when perfusion pressure was maintained constant at 160 torr. Under
these conditions, All did not elicit any further increases in GFR or
changes in the electrolyte excretion. Results indicate that the renal
perfusion pressure is a critical determinant of the renal responsiveness
to All and suggests that All enhances renal function at perfusion
pressures less than those customarily encountered in vivo.
Actions de l'angiotensine II sur le rein isolé de rats spontanément
hypertendus. Nous avons étudié les effets de l'angiotensine II (All) sur
les reins isolés de rats spontanement hypertendus (SHR) et Wistar-
Kyoto (WKY) en utilisant un perfusat recirculé dépourvu de cellules.
Des quantites de All suffisantes pour augmenter Ia résistance vasculaire
rénale (RVR) de 50% ont été perfusées. Quand Ia pression de perfusion
a ete augmentée en même temps que RVR pendant Ia perfusion de All,
il a eté observe des augmentations significatives du debit de filtration
glomCrulaire, du debit urinaire, de l'excrétion d'electrolytes, aussi bien
chez SHR que WKY. Cependant, quand on a empeche l'augmentation
de Ia pression de perfusion, All a augmenté le debit de filtration
glomerulaire des reins SHR, mais n'a pas eu d'effet sur celui des reins
de WKY. A la difference de ce qui a été observe dans WKY, All a
augmenté le debit de filtration glomerulaire, le debit urinaire, l'excré-
tion de sodium des reins SHR autant aux pressions de perfusion
'normotensives" qu'aux pressions de perfusion "hypertensives". Ce-
pendant, les pressions de perfusion "normotensives" utilisées dans cc
travail étaient inférieures a Ia pression sanguine des animaux SHR in
vivo. La réponse des reins SHR a All a été évaluée quand Ia pression de
perfusion a ete maintenue constante a 160 torrs. Dans ces conditions,
All n'a pas entrainé d'augmentation supplementaire du debit de filtra-
tion glomerulaire ou de modification de l'excrétion d'electrolytes. Les
résultats indiquent que Ia pression de perfusion rCnale est un détermi-
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nant critique de Ia réponse rénale a All et suggère que Al! augmente Ia
fonction rénale chez SHR a des pressions de perfusion inférieures a
celles habituellement recontrées in vivo.
The Kyoto spontaneously hypertensive rat (SHR) maintains
a level of renal function similar to normotensive Wistar-Kyoto
control rats (WKY) but at an elevated arterial pressure [1, 2, 3].
Reduction of the renal perfusion pressure in the SHR can lead
to sodium retention [41. In addition, glomerular filtration and
sodium excretion tend to be diminished in the isolated normo-
tensively perfused SHR kidney and increase when the perfusion
pressure is elevated [5].
Activation of the renin-angiotensin system is a common
consequence of antihypertensive therapy. Angiotensin II (All)
might affect renal function differently when the renal perfusion
pressure is lowered from its elevated pretreatment level. Ac-
cordingly, we have studied the effects of exogenous All on the
function of isolated perfused SHR and WKY kidneys at normo-
tensive and hypertensive perfusion pressures.
Methods
Thirty-two male SHR and 20 male WKY rats weighing 300 to
380 g were obtained from Taconic Farms (Germantown, New
York) and ranged in age between 15 and 20 weeks. They were
stabilized on chow containing 0.9% sodium chloride for at least
one week. In other similarly maintained rats obtained from this
supplier, mean arterial pressure during light ether anesthesia
averaged 99 5 torr (mean SEM) in WKY and 146 5 torr in
SHR.
After anesthesia with i.p. mactin (Promonta, Hamburg, Ger-
many), 80 to 100 mg/kg, the right kidney was isolated and
perfused with a cell-free solution [5, 6] after cannulation of the
right ureter with PE-50 tubing. A specially beveled 18-gauge
pediatric scalp vein needle was advanced retrograde from the
superior mesenteric artery into the right renal artery while
infusing a protein-free oxygenated flushing solution at 37° C and
a hydraulic pressure of 120 torr. The electrolyte composition of
this solution was similar to that of the perfusate given below
but, unlike the perfusate, it also contained 2% mannitol. The
kidney then was placed in a recirculating perfusion apparatus
described by Bowman [71, as modified by others [5, 6]. The
perfusion pump rate was adjusted to maintain the renal perfu-
sion pressure at 95 to 120 torr. The hydraulic pressure of the
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Table 1. Actions of All on isolated SHR and WKY kidneys°
GF
ml!
CON
R
mm
All
Urine flow
p.11mm
CON All
Sodium excre-
tion p.moles!min
CON All
FENA x
%
CON
100
All
FEK x
%
CON
100
All
Perfusion
pressure torr
CON All CON
RVR
PRU
All
SHR (N = 8)
Mean 0.29 0.60b 17 45 0.82 354b. 2.01 5.20t 29 53b 106 153b 2.98c 4.l5L
SEM (.04) (.09) (7) (10) (.08) (.76) (.74) (.87) (4) (10) (2) (7) (.18) (.31)
WKY (N = 7)
Mean 0.43 Ø74b 16 96b 1.23 7Q4b 1.63 6.95b 20 39b 100 156b 2.25 3.36b
SEM (.09) (.08) (7) (25) (.76) (2.05) (.88) (1.79) (5) (7) (2) (4) (.16) (.18)
a Superscripts indicate results of statistically significant differences (P < 0.05) as follows:
b Significant difference between angiotensin II (All) and control (CON) phases (paired t testing); significant difference from corresponding
WKY group (unpaired t testing). Renal vascular resistance (RVR) is given in units (PR U) of torr/ml/min.
perfusion system and perfusate flow were monitored continu-
ously. The resistance to flow imposed by the cannulating needle
had been determined previously over a wide range of perfusion
rates. The decrease in hydraulic pressure along the needle can
be determined, allowing calculation of the true renal perfusion
pressure and vascular resistance. The perfusate was maintained
at 37° C by thermostated water-jacketing and was equilibrated
continuously with humidified 95% oxygen and 5% carbon
dioxide.
Perfusate was prepared by the method of Ross, Epstein, and
Leaf [81. Bovine serum albumin, fraction V (Pentex®, Miles
Laboratories, Kankakee, Illinois) was dialyzed for 72 to 120
hours against a modified Krebs-Henseleit buffer containing
10,000 U/penicillin and 0.04 g streptomycin per 5 liters. On the
day of experimentation, frozen concentrated albumin was dilut-
ed to 7 g!dl in perfusate. The composition of the perfusate was
(in mM): sodium, 140; potassium, 4; bicarbonate, 22; chloride,
115; calcium, 2.5; magnesium, 0.75; and inorganic phosphate,
2.5. Perfusate also contained glucose and inulin, each at a
concentration of 100 mg/dl. The pH of this perfu sate was 7.40
during equilibration with 95% oxygen to 5% carbon dioxide. It
was passed through a Millipore filter prior to experimentation;
an additional Millipore filter was incorporated into the perfu-
sion circuit [5, 6].
After an initial 15- to 20-mm interval for equilibration, urine
and perfusate specimens were obtained for two or three control
periods of 10 to 15 minutes each. Then, an infusion of angioten-
sin II (Hypertensin®, Ciba-Geigy, Summit, New Jersey) was
begun. The angiotensin II (All) was dissolved in 0.15 M sodium
chloride and infused into the 60 ml of recirculating perfusate at
rates varying from 0.05 to 3.8 ng/min.
In "hypertensive" experiments done at a constant perfusate
flow, the All infusion rate was increased gradually until the
renal perfusion pressure increased by 45 to 60 torr. When renal
vascular resistance (RVR) became stable, urine and perfusate
specimens for two 10-mm periods were collected. In other
"normotensive" studies done at constant perfusion pressure,
perfusate flow was slowed sufficiently during All infusion to
prevent increases in the perfusion pressure during RVR eleva-
tion. For the latter protocol, sufficient All was administered to
elicit similar increases in RVR as in the constant-flow protocol.
Timing of the experimental periods was the same as for the
constant-flow studies. Other time-control studies were per-
formed with the infusion of the vehicle only (without All) in
order to define any spontaneous functional changes over the
time course of the experiments. Finally, an additional group of
SHR kidneys was perfused at 160 torr, with the pressure
maintained constantly at this value during All.
Analyses for inulin, sodium, and potassium were done as
previously described [5, 6]. Inulin clearance was used to
estimate the glomerular filtration rate (GFR). Fractional excre-
tions of sodium and potassium (FENA and FEK, respectively)
were calculated in the usual manner. For each experiment, the
values for control and experimental periods were averaged
separately. Statistical comparisons of changes between differ-
ent phases were done by paired t testing. Significant differences
between experimental groups were determined by unpaired
testing. P < 0.05 was taken as the level of statistical signifi-
cance.
Results
In an initial group of studies (Table 1), perfusate flow was
maintained constant during All, at 37 2 ml/min (mean SEM)
for SHR kidneys and 46 2 mI/mm for WKY kidneys. Under
these "constant flow" conditions, the renal perfusion pressure
during All increased by 47 6 torr in SHR kidneys and 56 4
ton in WKY kidneys (Table 1). During A!!, renal vascular
resistance (RVR) increased by an average of 39% in SHR and
49% in WKY kidneys. Both before and after All, RVR of the
SHR kidneys significantly exceeded that of WKY. As indicated
in Table 1, only urine flow and absolute sodium excretion after
All were significantly less in SHR kidneys than in WKY.
Although GFR, FENA, and FEK increased during A!! in both
SHR and WKY kidneys, the changes were comparable.
Less All was required to produce similar changes in RVR of
the SHR than the WKY kidneys. The amount of All required
for the SHR kidneys ranged from 0.32 to 0.77 ng/min and
averaged 0.52 0.04 ng/min when infused into 60 ml of
perfusate. In contrast, WKY kidneys required from 1.5 to 3.7
ng/min (mean 2.8 0.3 nglmin) to elicit the same increase in
RVR, a significantly greater amount (P < 0.001).
In other studies (Table 2), "normotensive" perfusion pres-
sures were maintained during A!! infusion by slowing the
perfusate flow rate proportionately to the increase in RVR.
Under these conditions, the responses of SHR and WKY
kidneys to All differed markedly. In the SHR kidneys, Al!
elicited a 65% increase in the GFR, as well as large increases in
urine flow, sodium excretion, and FENA (Table 2). In WKY
kidneys, All elicited changes only in urine flow and FENA,
despite the fact that their increases in RVR after A!! were
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Table 2. Actions of All on isolated SHR and WKY kidneys maintained at "normotensive" perfusion pressures
Sodium
GFR Urine flow
mi/mm p.1/mm
CON EXP CON EXP
excretion
p.moles/min
CON EXP
FENA x
%
CON
100
EXP
FEK x
%
CON
100
EXP
Perfusion
pressure torr
CON EXP CON
RVR
PRU
EXP
SHR
All during experimental periods (N 9)
Mean 0.37 0.61b 19 58" 0.90 3.16" 2.00 5.32b 34 26 119 119 3.82d 5.50bd
(sEM) (.07) (.14) (8) (14) (.17) (1.02) (.39) (1.62) (11) (8) (4) (5) (.44) (.56)
Time-control without All (N = 9)
Mean 0.34 0.30" 9 1I 0.55 0.65c 1.30 1.40 12' 14 116 117 3.14d 3.14'"
(saM) (.10) (.03) (2) (3) (.18) (.22) (.33) (.32) (3) (3) (5) (5) (.24) (.21)
WKY
All during experimental periods (N 8)
Mean 0.44 0.44 20 36b 1.10 1.8P 1.74 2.98b 22 26 109 115 2.61 4.27b
(saM) (.06) (.05) (7) (7) (.41) (.47) (.44) (.72) (5) (9) (5) (5) (.33) (.47)
Time-control without All (N = 5)
Mean 0.56 0.61 16 21 0.94 1.18 1.56 1.46' 16 17 108 109 1.87 1.81'
(sEM) (.06) (.11) (2) (4) (.13) (.26) (.32) (.04) (3) (4) (1) (1) (.15) (.16)
a Superscripts indicate results of statistically significant differences (P < 0.05) as follows: b Significant difference between experimental (EXP)
and control (CON) phases (paired I testing); significant difference from corresponding All group; d significant difference from the corresponding
WKY group.
Fig. 1. Effect of All infusion on the GFR in spontaneously hypertensive
rat (SHR) and Wistar-Kyoto control rat (WKY) kidneys maintained at
constant perfusion pressures of 105 to 120 torr. ALL elicited a significant
increase in SHR GFR but had no effect upon WKY GFR. Values are
means and SEM for the two periods immediately preceding and during
All infusion. Asterisks indicate a significant increase (P < 0.05) in SHR
GFR during All, compared to either of the control periods for the same
kidneys prior to All. In these kidneys, differences between SHR and
WKY GFR values were not significant.
equivalent to those of the SHR kidneys. In these experiments,
the WKY GFR remained constant at a value inbetween the
SHR GFR values before and after All (Fig. 1). Although the
GFR of the SHR and WKY kidneys did not differ significantly,
only the GFR of the SHR kidneys increased during both AL!
infusion periods (Fig. 1). Among the individual experiments
(Fig. 2), this increase in the GFR of SHR kidneys during Al!
was nearly consistent, as was the lack of response of WKY
GFR. All also increased SHR sodium excretion, but not that of
WKY, although the extent of variation in the results precluded
statistically significant differences in sodium excretion between
SHR and WKY kidneys during All.
1.0
0.8
U-
0.6
0.2
Control All Control All
Fig. 2. GFR and sodium excretion during individual experiments
conducted at constant "normotensive" perfusion pressures. Each
value is the mean of all measurements during the control and All
infusion phases in the same animal. All increased the GFR in most
spontaneously hypertensive (SHR) kidneys but not in Wistar-Kyoto
control rat (WKY) kidneys. All also increased SHR sodium excretion
significantly.
In order to determine the extent of spontaneous functional
changes in these isolated kidney preparations, SHR and WKY
time-control studies also were done (Table 2). In these time-
controls, without All, none of the measured parameters
changed. A tendency was absent for the GFR to increase
spontaneously in the time-control SHR or WKY kidneys.
Although the perfusion pressures utilized for the studies in
Table 2 are "normotensive", they are substantially less than
the arterial pressure of the SHR in vivo. Accordingly, other
constant-pressure studies were undertaken in SHR kidneys
maintained at a perfusion pressure of 161 torr (Table 3). At
these elevated renal perfusion pressures, control GFR values
All infusion0.8 -
0.6
0.4
0.2
U-0
1.4
1.2
— SHR
0-- WKY
I i I I
1 2 3 4
Clearance period
0.4
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Table 3. All actions on isolated SHR kidneys (N = 6) at a constant "hypertensive" perfusion pressurea
GFR
mi/mm
CON All
Urine
1.d/m
CON
flow
in
All
Na excretion
pmoles/min
CON All
FENA x
%
CON
100
All
FEK X
%
CON
100
ALL
Perfusion
pressure torr
CON All CON
RVR
PRU
All
Mean 0.85 0.66 22 28 1.08 1.41 1.25 1.90 15 18 161 161 2.43 3.68b
(sEM) (.19) (.13) (2) (7) (.12) (.26) (.25) (.26) (3) (3) (.1) (.1) (.11) (.19)
a Superscript b is defined in Tables 1 and 2.
significantly exceeded those of any of the "normotensively"
perfused SHR groups (Tables 1, 2). Again, sufficient All was
infused to increase RVR by approximately 50%. However,
under these "hypertensive" constant-pressure conditions,
there were no changes in GFR, urine flow, or electrolyte
excretion. Of interest, the SHR GFR values at "hypertensive"
perfusion pressures during All (Tables 1, 3) were very similar to
the values during All at "normotensive" perfusion pressures
(Table 2).
Discussion
Isolated rat kidney preparations perfused with cell-free media
manifest a very low vascular resistance and filtration fraction
compared to the kidney in vivo [101. The low filtration fraction
can be increased by the addition of heterologous red blood cells
[11, 121 but only at the hazard of introducing additional experi-
mental variables and creating technical difficulties. In one
report [11], the addition of ox red blood cells to a similar
preparation resulted in filtration fractions of only 0.04 to 0.05.
Other parameters of the kidney's function do not suffer greatly
in comparison [10, 13]. Sodium transport in superficial proximal
and distal tubules is essentially normal in the isolated prepara-
tion [13].
Our isolated perfused SHR kidneys responded to smaller
amounts of All than WKY kidneys, an observation consistent
with the report of Berecek, Schwertschlag, and Gross that
isolated kidneys from stroke-prone SHR manifest increased All
sensitivity [9]. Whether this arises from differences in A!!
receptors in the SHR kidney or from vascular structural
changes occurring in the course of hypertension is not clear.
The latter could contribute to abnormal perfusion characteris-
tics of SHR kidneys [14]. All increased the GFR of our SHR
kidneys only at perfusion pressures less than those encountered
in vivo. Elevation of the perfusion pressure itself increased the
GFR substantially, and no further increase was elicited by
adding All during "hypertensive" constant-pressure perfusion.
These results indicate that the perfusion pressure must be
considered in evaluating the effect of All on renal function.
Dávalos et al have studied the action of exogenous [15] and
endogenous [16] All on isolated kidneys from normal rats,
perfused at a mean hydraulic pressure of about 70 torr. All
increased the GFR and filtration fraction, suggesting a selective
constriction of the efferent arteriole [15, 16]. Sodium excretion
was not affected. In our "normotensive" constant-pressure
studies, All did not affect either the GFR or absolute sodium
excretion in WKY kidneys but increased both parameters in
SHR kidneys. The latter action of All was absent in SHR
kidneys perfused at constant "hypertensive" pressures, sug-
gesting that it requires a renal perfusion pressure which is less
than the arterial pressure in vivo. The marked diuresis and
natriuresis after All in the "normotensively" perfused SHR
kidneys could have resulted solely from an increase in filtered
sodium, although the absence of a kaliuretic effect of All tends
to argue against an increase in the distal delivery of tubule fluid.
Ichikawa and Brenner have suggested that opposing interac-
tions of All and prostaglandins on the efferent arteriole vascular
tone are important in the regulation of proximal glomerulotubu-
lar balance [17]. All could have activated prostaglandin synthe-
sis in our experiments [18]. Also, a preliminary report indicates
that the capability for synthesis of PGI2 and thromboxane A2
(TXA2) is increased in SHR glomeruli [19]. Additional experi-
ments are needed in order to delineate the contribution of
prostaglandins to functional changes during All action on the
SHR kidney.
Our data raise the possibility that activation of the renin-
angiotensin system might favor the preservation of a normal
GFR during antihypertensive treatment and prevent sodium
retention. Angiotensin converting enzyme inhibitors can treat
successfully hypertension in humans and in the SHR [20, 21],
presumably without substantially compromising renal function.
In a recent report, neither teprotide (SQ2O,881) nor captopril
(SQ14,225) inhibited All generation by kidney tissue [22],
possibly as a consequence of tonin action [23]. This property, if
confirmed in the rat, would allow renal All generation to
continue in spite of systemic converting enzyme inhibition.
In summary, All selectively increases glomerular filtration
and sodium excretion in the "normotensively" perfused isolat-
ed SHR kidney, suggesting that All enhances renal function at
perfusion pressures less than those customarily encountered in
vivo. The exact mechanism underlying this action of All and its
significance in human hypertension await clarification.
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